Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
78.93
-0.39 (-0.49%)
At close: Jul 2, 2026, 4:00 PM EDT
78.94
+0.01 (0.01%)
After-hours: Jul 2, 2026, 7:31 PM EDT
Liquidia Revenue
Liquidia had revenue of $132.87M in the quarter ending March 31, 2026, with 4,158.49% growth. This brings the company's revenue in the last twelve months to $288.07M, up 1,936.66% year-over-year. In the year 2025, Liquidia had annual revenue of $158.32M with 1,031.18% growth.
Revenue (ttm)
$288.07M
Revenue Growth
+1,936.66%
P/S Ratio
24.37
Revenue / Employee
$1,333,634
Employees
216
Market Cap
7.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.32M | 144.32M | 1,031.18% |
| Dec 31, 2024 | 14.00M | -3.49M | -19.97% |
| Dec 31, 2023 | 17.49M | 1.55M | 9.75% |
| Dec 31, 2022 | 15.94M | 3.08M | 23.98% |
| Dec 31, 2021 | 12.85M | 12.11M | 1,637.77% |
| Dec 31, 2020 | 739.63K | -7.33M | -90.84% |
| Dec 31, 2019 | 8.07M | 5.37M | 198.20% |
| Dec 31, 2018 | 2.71M | -4.55M | -62.70% |
| Dec 31, 2017 | 7.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.89B |
| Dr. Reddy's Laboratories | 3.58B |
| Neurocrine Biosciences | 3.10B |
| Amneal Pharmaceuticals | 3.05B |
| Hims & Hers Health | 2.37B |
| Alkermes | 1.56B |
| Lantheus Holdings | 1.55B |
| Indivior Pharmaceuticals | 1.29B |
LQDA News
- 4 days ago - Liquidia downgraded to Neutral from Buy at BofA - TheFly
- 11 days ago - Liquidia price target raised to $109 from $59 at BTIG - TheFly
- 16 days ago - Liquidia Transcript: AGM 2026 - Transcripts
- 22 days ago - Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions - GlobeNewsWire
- 25 days ago - Liquidia announces inclusion in S&P SmallCap 600 Index - TheFly
- 25 days ago - Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index - GlobeNewsWire
- 4 weeks ago - Liquidia price target raised to $75 from $67 at H.C. Wainwright - TheFly
- 4 weeks ago - Raymond James sees positive readthrough for Liquidia from Hikma v. Amarin - TheFly